Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Cingulate Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Silva Raul R. (EVP and CSO) has filed a Form 4 on Cingulate Inc.
Txns: Granted 10,000 options to buy @ $0.709, valued at $7.1k
10/02/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/22/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
08/14/2023 SC 13D/A Werth Peter J. reports a 18.1% stake in Cingulate Inc.
08/14/2023 4 Werth Peter J. (Director) has filed a Form 4 on Cingulate Inc.
Txns: Bought 1,823,155 shares @ $0.5485, valued at $1M
08/14/2023 3 Werth Family Investment Associates LLC (10% Owner) has filed a Form 3 on Cingulate Inc.
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of August 11, 2023, between Cingulate Inc., a Delaware corporation , and the purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act , and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows: ARTICLE I. ...",
"[email protected]"
08/01/2023 8-K Quarterly results
07/25/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/25/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/25/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/25/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
07/11/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/08/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/18/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/16/2023 4 Callahan Jennifer L. (Corporate Controller) has filed a Form 4 on Cingulate Inc.
Txns: Bought 4,000 shares @ $1.08, valued at $4.3k
Bought 2,000 shares @ $1.01, valued at $2k
Bought 1,030 options to buy @ $6, valued at $6.2k
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "AMENDED AND RESTATED PROMISSORY NOTE",
"Elixir Health Public Relations"
05/05/2023 ARS Form ARS - Annual Report to Security Holders:
05/05/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/05/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/05/2023 8-K Quarterly results
05/05/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/03/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Elixir Health Public Relations"
05/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/02/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
04/26/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
04/26/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/25/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy